Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of gefitinib in treating patients who have stage
IIIB or stage IV non-small cell lung cancer. Biological therapies such as gefitinib may
interfere with the growth of the tumor cells and slow the growth of non-small cell lung
cancer